Lymphedema is a chronic debilitating condition that most commonly results from treatment of cancer in the industrialized modern world. While lymphedema can certainly affect the upper and lower extremities, this article focuses on the surgical treatment of lymphedema following the treatment of breast cancer (►Fig. 1). Several studies have aimed to examine the risk factors for developing postmastectomy lymphedema syndrome and have identified the most dangerous risk factors to be axillary lymph node dissection, radiation therapy, chemotherapy, and obesity, typically reported as body mass index. [1] [2] [3] [4] While lymphedema can certainly result from even a sentinel node biopsy reported in up to 3 to 8% of patients, the greatest risk factor is associated with the number of nodes removed. [5] [6] [7] However, the risk of lymphedema is not stagnant but can change over time.
Historically, lymphedema was treated with debulking, ablative procedures where the excess volume consisting of fat and fluid was directly excised or removed through liposuction. 8, 9 However, these approaches are far from physiologic and are often disfiguring and barbaric or can only achieve temporary improvement. Although it was first described in the 1960s, the field of lymphedema surgery and supermicrosurgical treatment of lymphedema through a lymphovenous bypass (LVB) or lymphaticovenular anastomosis (LVA) has only recently become more common and is considered one of the gold standard treatments for lymphedema.
10
The field of lymphedema surgery and supermicrosurgery is rapidly expanding since its original description, and recent studies have demonstrated promising results.
11-14 The technique depends on the identification of lymphatic channels, most commonly through imaging with indocyanine green (ICG) and fluorescent imaging. These devices use an infrared camera to detect the ICG dye that is absorbed into the lymphatic channels. [15] [16] [17] [18] [19] However, there are several different techniques that have been employed for the identification of the lymphatic channels. Computed tomography (CT), lymphoscintigraphy, and magnetic resonance lymphangiography have also been used for the identification of the lymphatic vessels in preparation of LVBs. [20] [21] [22] Unfortunately, these imaging modalities have been used in limited studies, and the use of ICG remains the gold standard for the identification of the lymphatic vessels.
23
Once a suitable channel is identified, a recipient vein is necessary and supermicrosurgical techniques are used to create an anastomosis between the two. The identification of the recipient vein, however, poses another challenge to the supermicrosurgeon. With the use of ICG lymphangiography, the lymphatics are readily visualized; however, the recipient veins and venules can also be identified not by fluorescence but as a shadow crossing over the lymph vessels (►Fig. 2). Other techniques that have been described for localization of the veins include ultrasonography or echography, which can Keywords ► lymphedema surgery ► lymphovenous bypass ► lymphaticovenular anastomosis
Abstract
The field of lymphedema surgery has witnessed tremendous advancements over the years and has been coupled to the rapid growth of supermicrosurgical techniques. A lymphovenous bypass or lymphaticovenular anastomosis is a new technique that requires identification of patent, residual lymphatic channels and performing an anastomosis to a recipient venule, thereby allowing outflow of lymphatic fluid and improvement in a patient's lymphedema. This article provides a summary of the maturation of the technique, as well as the technical aspects of the approach and the current outcomes in the treatment of postmastectomy lymphedema.
certainly enhance and facilitate the LVA procedure.
24,25
However, while there may be benefits of the use of additional imaging technologies for identifying both the veins and the lymphatics for performing an LVB, the only critical imaging modality that has been agreed upon by surgeons who perform high-volume lymphedema surgeries is ICG.
26-28

Surgical Technique
Once the vessels have been identified cutaneously, finding them to perform the actual anastomosis also requires time, meticulous technique, and experience. The ICG lymphangiography only provides guidance as to where the incision is made, but to localize the lymph vessel and the vein can often be tedious. Prior to making the incision, the planned location is infiltrated with local anesthetic containing epinephrine for hemostasis in order to limit bleeding from the dermal edges. Isosulfan blue or Lymphazurin (Covidien) is injected distal to the incision site, which is absorbed into the lymphatic vessel and allows for visualization of the lymphatic during the dissection. While visualization of the blue dye certainly makes the dissection easier, lymphatic channels may be present and suitable for the LVA that does not contain any dye (►Fig. 3).
Once the lymph vessel and the recipient vein are identified, the anastomosis presents unique challenges to the operating microsurgeon. Lymphedema surgery, while considered supermicrosurgery, remains grounded in the basic premises of microsurgery. 29 The anastomosis between the lymphatic vessel and the recipient venule still requires careful tissue handling and appropriate placement of sutures with full-thickness bites, making certain that there is no back-walling of the vessels to ensure patency of the anastomosis. 30 However, while this is easily achievable in vessels measuring approximately 1 mm in size, the task becomes progressively more difficult and challenging as the vessels decrease in size. Several different approaches have been described to perform the anastomosis; however, microscopes with high magnification optics are paramount in achieving successful bypasses, coupled with surgical technique and skill and experience. However, the precise technique by which the anastomosis is completed is fairly variable and is dependent on surgeon preferences and philosophies. Given the submillimeter size of the lymphatic vessels and recipient veins, the anastomosis presents unique challenges. The lymphatic channel, in particular, is often smaller than the vein, and the walls of the lymph vessels are especially thin and often collapse on themselves, making it difficult to place the needle into the lumen. One technique that has been described uses a suture to serve as a stent to identify the lumen and maintain its patency while performing the LVA (►Fig. 4). The most commonly used suture is a 6-0 Prolene (Ethicon Inc.) or monofilament suture, which often represents the limit of what is technically achievable with current optics and instruments. 31, 32 In the setting where the recipient vein is much larger in size, the size mismatch can be difficult to overcome. Under these circumstances, an end-to-side anastomosis can be performed, where the lymphatic channel is joined to the recipient vein in an end-to-side orientation rather than an end-to-end fashion. However, aside from the size mismatch, there is concern that the venous pressure may exceed the lymphatic pressure, which would prevent the drainage of lymphatic fluid into the vein. The stent technique has also been applied to other orientations of the lymphovenous anastomosis. Some proponents of the lymphatic bypasses believe that lymphatic fluid can drain bidirectionally; therefore, the most optimal orientation would be to perform an anastomosis with the end of the vein to the side of the lymphatic channel allowing drainage from the proximal and distal extremity, a so-called side-to-end anastomosis.
32-34
The side-to-end anastomosis can be performed using a stent as well, or, alternatively, the sutures can be parachuted around the anastomosis with equivalent success rates and again would allow bidirectional drainage of lymph fluid into the venous circulation. 35 Another option to allow bidirectional drainage would be to perform two end-to-end anastomoses of both the antegrade and retrograde ends of the lymphatic vessel into a recipient vein, which also allows both the proximal and distal extremities to drain and theoretically maximizes the drainage of fluid from the lymphatic system.
36
As previously noted, a size mismatch often exists between the recipient vein and the lymphatic vessel, which can create an unfavorable pressure gradient where the venous pressure exceeds that of the lymphatic system and can lead to failure of the bypass. Some have proposed the technique of funneling several lymphatic channels into a single larger caliber vein, which will increase the pressure of the lymphatic vessels to overcome any venous hypertension to allow drainage of lymphatic fluid into the venous system. Early studies, while preliminary, were very promising. Koshima et al performed lymphaticovenular bypasses in 12 patients and compared their response to patients who were only treated with compression wrapping and found a significant improvement in patients' lymphedema with an average decrease in arm circumference by more than 4 cm. 39 Similarly, Chang demonstrated a 95% subjective improvement with a 35% volume reduction at 1 year following LVBs in a prospective study including 20 patients. 40 Since their early experience, both experts have developed and described their staging criteria for classifying the severity of lymphedema as well as providing a means to guide surgical treatment and have reported similar findings in larger studies.
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The larger follow-up studies by Chang et al again demonstrated a 96% subjective response rate, where patients reported an improvement in the sensation of heaviness in the affected limbs, the incidence of infections and cellulitis, and dependency on compression garments. Despite the overwhelming improvement in subjective symptoms, the volumetric measurements only demonstrated a reduction in limb volume in 74% of patients with an average 42% volume reduction at 12 months. 42 However, the overall success of the operation is mirrored in other studies, which have also demonstrated a significant benefit to patients who have undergone an LVA and, given their initial successes, have continued to define the field by describing novel techniques and approaches to the treatment of lymphedema. 43, 44 One such modification of the technique involved the distinction between the deep and superficial lymphatic system, where they demonstrated the ability to perform an LVA in patients who have lost the superficial lymphatic system but have preservation of the deep system. In patients with this scenario, an LVA can still be effective if performed properly despite the fibrosis and sclerosis of the superficial lymphatic channels.
45
Other institutions that perform lymphedema surgery have also demonstrated similar outcomes; however, certainly, the number of institutions with high-volume and long-term outcomes are limited. Studies have demonstrated a certain percentage of thrombosis or sclerosis of the bypasses following an LVA, which can lead to recurrent lymphedema and swelling over time. However, studies with a minimum of 1-year followup or longer have still demonstrated promising results confirming the efficacy of this approach for treating lymphedema. [46] [47] [48] This highlights the need for experience and an indepth understanding of supermicrosurgical techniques, as well as the anatomy and physiology of the lymphatic system. Once the anastomosis is completed, the final outcome and improvement in patient symptoms are obviously dependent on a patent anastomosis. Often times, the isosulfan blue can be seen draining into the recipient venule, but there are often circumstances when there is no dye visualized in the lymphatic and therefore it can be difficult to ascertain whether the anastomosis is patent and functional (►Fig. 5). A gentle strip test can sometimes confirm patency and drainage of fluid through the bypass; however, some microscopes are equipped with an ICG filter that will allow detection of ICG passing through the anastomosis to confirm that the bypass is patent and draining. 49, 50 Regardless of which modality is used, a confirmatory test is vital in ensuring a patent anastomosis, which obviously dictates the success of the entire operation.
Postoperative Management
If the bypass is functional, patients may notice an immediate improvement in their arms following the procedure (►Fig. 6).
Patients are typically asked to refrain from using any type of conservative measures such as compression sleeves, wrapping, performing manual lymphatic drainage, or using pneumatic pump devices for 4 weeks to allow the bypasses to mature.
28,51
The overwhelming majority of patients have a significant improvement in their quality of life and are able to decrease the amount of time, effort, and resources committed to maintaining their lymphedema. The need to wear compression sleeves, the time wasted in undergoing pneumatic pump therapy, the time spent in traveling and undergoing manual lymphatic drainage and massage with lymphedema therapists, and the risks of infection have all been reported to improve following the LVA.
42,52
Discussion
The LVB or LVA procedure is an effective and physiological operation that can have a profound impact on patients suffering from breast cancer related lymphedema. If performed appropriately, the success rates for minimizing the morbidity of lymphedema and improving patients' quality of life is remarkably high and well-documented in the literature. However, while the ability to perform a successful bypass is reminiscent of standard microsurgical reconstruction, the operations are far from identical, and a proficient microsurgeon with extensive skills and expertise in free-flap reconstruction does not guarantee that one can perform lymphedema supermicrosurgery. Success rates are multifactorial and reflect not only the surgeon's skill, expertise, and experience, but also require a multidisciplinary approach involving certified lymphedema therapists as well as the technology enabling the team to diagnose and stage a patient's lymphedema with ICG lymphangiography and the appropriate equipment, instruments, and microscope that allow the operation to be completed. Although the success rates are truly effective in improving patients' lymphedema using the LVA, the operation does not cure lymphedema. Patients must still be cautioned that they may need to wear their compression garments when they fly or engage in more strenuous activities. Patients are still instructed to be cognizant of risks of infection and should avoid any trauma to the arm that can precipitate worsening swelling or cellulitis. Despite studies demonstrating no increased risks of complications with some of these historic precautions including laboratory draws, blood pressure cuffs, and flying, most surgeons treating lymphedema still maintain these restrictions.
53
With the proven benefits of the LVB and LVA procedure, some have even begun performing a lymphatic venous anastomosis at the time of the axillary dissection. Preliminary results have demonstrated significant benefits in reducing the risks of developing lymphedema. 54, 55 In one study including less than 50 patients, a prophylactic LVB performed at the time of the axillary node dissection significantly reduced the incidence of lymphedema from 30.4 to 4.3%, which correlated with a smaller volumetric difference at 3, 6, 12, and up to 18 months followup. 56 The findings have been further reinforced with larger series and longer follow-up, again confirming the efficacy and safety of this approach. 57, 58 However, the long-term patency and efficacy of the LVB/LVA remain to be determined. Whether or not the anastomoses remain patent and provide a permanent benefit for patients is an area of active investigation. While the prophylactic LVB, so-called lymphatic microsurgical preventive healing approach, has demonstrated promising outcomes in preventing lymphedema in breast cancer patients undergoing axillary dissection, concerns regarding the impact on cancer treatment and metastases remain to be determined. Furthermore, the effect of radiation and chemotherapy on the longterm patency and efficacy of the prophylactic LVA also remains unknown. Overall, this operation has had a profound impact with a dramatic improvement in the overwhelming majority of patients who have been treated. The widespread implementation of this technique, however, is still limited, and the majority of operations and studies come from a select group of specialized, high-volume institutions across the world. However, as the number of professionals trained to perform the LVA grows, the number of patients who will benefit from this operation and achieve some relief from their debilitating condition will hopefully increase as well.
Conclusion
The LVB or LVA technique is an effective operation and, when performed properly, can provide significant, reproducible benefits in improving the quality of life of patients suffering from breast cancer related lymphedema. The full potential of the LVA remains to be determined, and future studies are needed to optimize the long-term outcomes and applications of this operation for the treatment of lymphedema.
